Will Immunitybio Inc (IBRX) Stay at the Top of the Healthcare Sector?

A rating of 61 puts Immunitybio Inc (IBRX) near the top of the Healthcare sector according to InvestorsObserver. Immunitybio Inc's score of 61 means that it ranks higher than 61% of stocks in the sector. In addition, its overall score of 79 ranks it higher than 79% of all stocks.

IBRX has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on IBRX!

See Full IBRX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Immunitybio Inc Stock Today?

Immunitybio Inc (IBRX) stock is trading at $5.78 as of 11:44 AM on Thursday, Mar 28, a gain of $0.32, or 5.77% from the previous closing price of $5.46. The stock has traded between $5.35 and $5.82 so far today. Volume today is light. So far 1,626,313 shares have traded compared to average volume of 4,746,730 shares. Click Here to get the full Stock Report for Immunitybio Inc stock.